Saturday 17 October 2026
Export MEDS’s income statement to Excel — free account
DataMeds AI, Inc
MEDS Healthcare Pharmaceutical Retailers
DataMeds AI, Inc’s revenue for fiscal 2025 (year ended December 2025) was $23.3 million, up 28.7% from fiscal 2024. In the quarter to June 2026, revenue fell 77.2%, EPS fell 29.6%, free cash flow fell 41.9% and total debt fell 15.4%, each against the same quarter a year earlier.
2.63
0.22
−7.72%
Follow MEDS
DataMeds AI, Inc (MEDS) P/E ratio
DataMeds AI, Inc has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 5 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BIMI BIMI Holdings Inc. compare | n/m |
| RDGT Ridgetech Inc. compare | n/m |
| MDVLQ MedAvail Holdings, Inc. compare | n/m |
| PETS PetMed Express, Inc. compare | n/m |
| HITI High Tide Inc. compare | n/m |
| SCNX Scienture Holdings, Inc. compare | n/m |
| MEDS DataMeds AI, Inc | n/m |
| POM Pomdoctor Limited - Sponsored ADR compare | — |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)